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ToxicityAbstract Marine Streptomyces ruber EKH2 isolated from sediments of Bardawil Lake, Egypt, was
found as a promising strain for producing bioactive metabolite(s) working against some virulent
ﬁsh pathogens. Some biochemical and morphological characterizations of marine S. ruber EKH2
were carried out. Cell free culture showed activities against the tested pathogens ranging from
15 to 30 mm. Optimized conditions for maximum activities were observed at neutrality and
temperature 28 C against the tested strains. Two grams of the ethyl acetate crude extract from
10 L culture supernatant was chromatographically separated into three fractions and bioassayed.
One major antibacterial compound was separated exhibiting MIC average 12.5 lg/ml. Phthalic acid
was structurally suggested on the basis of gas chromatography–mass spectrum (GC–MS) and
infrared spectrum (IR). Phthalate activities were compared with known standard antibiotics
used in ﬁsh therapy and found to be superior. A slight toxicity of phthalate against brine shrimp
(LC50 = 2800 lg/ml) was observed. Dealing with pan-drug resistant bacteria in ﬁsh therapy, this
study conﬁrmed that marine S. ruber EKH2 is potentially used for extracting phthalic acid as a
novel bioactive and non-toxic agent for treating bacterial ﬁsh infections.
ª 2015 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Over the last decades, world aquaculture industry has
obviously grown. This development has been represented by
a transition that involves a lot of work in farming methods
which encourages an increased proﬁtability (Food, 2012).
Facing the fact, an increased threat of many diseases caused
by a vast number of virulent microbes resulted in considerableeconomical losses. In order to develop rapid diagnostic tests
and effective disease precautions, all research activities have
been carried out with prevention strategies (Frans et al.,
2013).
Recently, new therapeutic agents have entered the clinical
area, with side effects (Rajan and Kannabiran, 2014). Side
effects of existing drugs and drug resistance have become
serious public health problems for both human and animals
which require the development of new antimicrobial agents
(Urban et al., 2003). Many scientists are working on new
antimicrobial drugs, mainly of actinomicetal origin (Oskay
et al., 2004; Paterson et al., 2004), where unique chemical
structures obtained from actinomycetes are considered as
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cytotoxic metabolites (Kekuda et al., 2010). Until recently,
actinomycetes isolated from marine sediments, as the least
explored resources, showed to be a source of bioactive com-
pounds production; however, today it became one of the more
promising sources.
Species of Streptomyces as versatile producers of new sec-
ondary metabolites from different biosynthetic pathways,
originate from different ecological niches and could be used
to hunt for novel bioactive compounds (You et al., 2013).
Marine ecosystems with a large diversity of actinomycetes have
the power of producing bioactive secondary metabolites
(Olano et al., 2009a). Regarding secondary metabolic produc-
tion from microorganisms isolated from the deep sea, it has
been found to remain normally dormant or weakly expressed
under laboratory conditions, which was critical for metabolite
development prior to extensive chemical investigation (Ochi
and Hosaka, 2013).
Bioactive compounds from marine actinomycetes of unique
structure and obvious effect have been obtained; however, how
to tap these treasurous compounds? (Li et al., 2013). Olano
et al. (2009b) suggested that Streptomyces isolates from marine
sediments are valuable for the production of antibiotics.
Compounds synthesized by most Streptomyces species with
broad spectrum features, including antibiotics, pesticides,
herbicides, enzyme inhibitors and anti parasitic, are
more importance to tend healthily and commercially effective
drugs, and occupy approximately one third of the known
isolated metabolites from Streptomyces (Balagurunathan
et al., 2010).
Therefore, the purpose of this study is to evaluate,
in vitro, the antagonistic activity of a bioactive metabolite
from marine Streptomyces ruber EKH2 against some
virulent ﬁsh pathogens. Moreover, the study would extend
to separate, analyze and characterize the crude extract using
thin layer chromatography, and be identiﬁed by gas
chromatography–mass spectral (GC–MS) and infrared
spectroscopic analysis.
Materials and methods
Isolation and characterization of S. ruber ekh2
Marine S. ruber EKH2 was isolated from Bardawil Lake
sediment samples, Sinai Peninsula, Egypt, and identiﬁed by
Xcelris Genomics labs in India. Luria–Bertani medium (LB),
used for isolation, consisted of (g/l sea water); tryptone, 10;
yeast extract, 5 and sodium chloride, 10, agar 20; pH adjusted
at 7 and incubation temperature at 30 C (Kandpal et al.,
2012). Microscopic and morphological examinations were
noted with respect to type of cells, aerial mycelium color,
nature of colony and reverse side plate color.
Fish pathogens
The ﬁsh pathogens including Aeromonas hydrophila,
Edwardsiella tarda, Pseudomonas aeruginosa and Vibrio ordalii
employed for in vitro antimicrobial assay were kindly provided
from the Department of Poultry and Fish Diseases, Faculty of
Veterinary Medicine, Alexandria University. The tested
pathogens were stored in glycerol at 20 C.Fermentation condition and Bioactivity
One hundred milliliter of the production LB broth medium
was inoculated by 2 · 107 CFU/ml spores suspension. Flasks
were kept for 5 days at 120 rpm shaker speed and 30 C
(Deepika and Kannabiran, 2010). Fermented medium was col-
lected and centrifuged from cell debris for further use as the
crude extract.
Bioactivities were screened using disc diffusion method on
tryptic soya agar (TSA) (Bauer et al.,1966). Twenty-ﬁve milli-
liter of sterilized TSA medium were mixed with 400 ll of
over- night culture of tested organism (104 CFU/ml), then
poured into three sterile Petri-dishes, as replicates, and
allowed to solidify. Sterile plain discs (5 mm) were immersed
in free cell ﬁltrate of the cultivated S. ruber EKH2, and
placed on the prepared plates then incubated at 30 C
overnight.
Extraction of bioactive compounds
For the extraction of the bioactive metabolites from fermented
broth, different organic solvents (50 ml each) from polar
(butanol, diethyl ether and ethyl acetate) to non-polar
(benzene, hexane and petroleum ether) were tried for product
recovery from 50 ml fermented broth in a 250 ml separating
funnel. The mixture was shaken vigorously for 20 min and
kept in stationary condition for another 20 min to separate
the solvent from aqueous phase (Atta and Ahmad, 2009).
Minimal inhibitory concentrations (MIC) of the ethyl acet-
ate extracted compound(s) were determined according to
Richard et al. (2007). For maximum conditional activity,
MIC was recorded at different temperatures (28, 37 and
45 C) and pHs (6, 7, 8) in three replicates using representative
response surface plot curves, STATISTICA (ver. 8, ed. 2006).
Thin layer chromatography
The culture broth (10 L) was extracted with ethyl acetate (1:1
v/v) stepwise and concentrated by rotary evaporator at 50 C
to yield 2 g of brown crude residue. The residue was
chromatographed on silica gel preparative slides using differ-
ent solvent systems: acetone, hexane and ethyl acetate, sepa-
rately, or combined solvent systems; acetone:ethyl acetate
(1:2), acetone:ethyl acetate. (2:1), hexane: ethyl acetate (1:2),
and hexane: ethyl acetate (2:1). The starting crude spots were
observed for migration and separation by the previously
prepared mobile phases. Rf values of the obtaining colored
and non-colored spots with the aid of visible and UV lamps
were recorded (Usha et al., 2010). Using silica gel plates
(20 · 20 cm dimensions and 0.50 mm thickness of 60GF254
ﬁne grade), the active bands were gathered, dissolved in ethyl
acetate and concentrated to dryness in the vacuum.
Bioactivity of the selected bands was examined against the four
pathogens using the broth dilution bioassay.
Spectral analysis
Gas chromatography–mass spectrum
The active fraction was analyzed using the SHIMADZU
GC–MS-QP5050A with programm CLASS 5000 in the
Central Lab of the Higher Institute of Public Health.
Table 1 Morphological and biochemical characteristics of S.
ruber EKH2.
Characteristics Utilization of
sole carbon sources
Color of aerial
mycelium
Greenish-white Fructose +
Reverse color Faint cream Inositol +
Diﬀusible pigment Pale yellow Mannitol +
Spore chain
morphology
Spiral Sucrose +
Spore surface Smooth Xylose +
Figure 1 Scanning electron micrograph of S. ruber EKH2
showing smooth spore surface. The bar represents 1 lm.
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SPECTRAL DATA BASE Library (Aravamuthan et al.,
2010).
Infrared
One mg sample of extracted crude was subjected to IR-spectral
analyses using Infrared Spectrophotometer (Perkin Elmer,
Spectrum). Mid IR region of 400–4000 cm1 was used for
sample analysis. A mixture of spectroscopic pure KBr was in
the ratio of 5:95; pellets were ﬁxed in sample holder.
Antibiogram
Fish pathogens were screened for their sensitivity towards
standard antibiotics used in ﬁsh therapy including amikacin
(AN, 30 lg/ml), ciproﬂoxacin (CIP, 30 lg/ml), ﬂorfenicol
(KF, 50 lg/ml) and rifamycin (RD, 50 lg/ml). MIC values of
these antibiotics compared with the active fraction were per-
formed using serial dilution method. 0.5 McFarland standards
were used to adjust spectrophotometric concentrations of the
tested pathogens (Zhang et al., 2012).
Biotoxicity
The biomarker brine shrimp ‘‘Artemia salina’’ was used for
toxicity assay according to Meyer et al. (1982). Two hundred
mg of the active fraction was dissolved in 2 ml dimethylsulfox-
ide (DMSO). In glass vials, varied crude concentrations (10,
20, 50, 100, 150, 200, 400 and 600 lg/ml) were added to
20 ml of sterilized brackish water. Ten A. salina nauplii were
transferred to each vial. Biomarker viable count was recorded
after 24 h of application. Using probit analysis method, the
mortality percentage and half lethal concentration (LC50) of
examined nauplii were determined (Reish and Oshida, 1987).Figure 2 Antimicrobial activities of cell free culture S. ruber
EKH2, against some bacterial ﬁsh pathogens.Results and discussion
S. ruber EKH2 isolated from marine sediment was found to
produce active phthalate for treating bacterial ﬁsh infections.
Culture free cell bioassay and optimized conditions for maxi-
mum activities were determined against the tested pathogens.
Phthalate as the major active and non-toxic compound was
separated and structurally suggested using GC–MS and IR
spectral analysis.
Characterization of S. ruber EKH2 and bioassay
S. ruber EKH2 was morphologically examined with respect to
the color of aerial mycelium, nature of colony and reverse side
color; and biochemically by its assimilation of various carbon
sources as shown in Table 1. Spore surface and chain morphol-
ogy are shown in Fig. 1 using scanning electron microscope.
Cell free culture showed broad spectrum activities against
A. hydrophila, E. tarda P. aeruginosa and V. ordalii; 30, 27,
22 and 15 mm, respectively, (Fig. 2). Compared to our results,
a marine Streptomyces strain showed the highest activities 26,
23 and 28 mm against P. aeruginosa, Staphylococcus aureus
and Escherichia coli, respectively (Nandhini et al., 2013);
whereas, the bioactive metabolite produced by Streptomyces
aureofaciens showed antibacterial activity ranging 10–12 mmfor Staphylococcus and 13–15 mm for Pseudomonas spp.
(Vennila and Krishnaveni, 2013). Marine Lactobacillus
murinus AU06 showed broad spectrum activities against some
ﬁsh pathogens with ranges of 24 mm for S. aureus, 22 mm for
P. aeruginosa, 18 mm for E. coli but no activity for Vibrio sp.
(Elayaraja et al., 2014).
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The best solvent for extraction process was ethyl acetate show-
ing the highest values of inhibition zone at 35, 30, 28 and 12 mm
against A. hydrophila, E. tarda, P. aeruginosa and V. ordalii,
respectively. Other polar and non-polar solvents showed differ-
ent tendencies for the antimicrobial activity against the four
tested pathogens (Table 2). Anusha et al. (2014) reported that
the ethyl acetate extracts from herbs showed the maximum
antibacterial activity of 18 mm against the virulent ﬁsh patho-
genic strain A. hydrophila CMST. Therefore, ethyl acetate sol-
vent was selected for further testing.
Optimum pH and temperature were recorded at 7 and
28 C showing the highest value of MIC at 4, 12, 24 and
48 lg/ml against A. hydrophila, E. tarda, P. aeruginosa and
V. ordalii, respectively (Table 3). The interaction of the initial
pH values and incubation temperatures was graphically illus-
trated in Fig. 3 using response surface plot.
Different pHs indicated the tendency of the bioactive
metabolite production to increase in acidic rather than basic
condition against the four tested pathogens. The maximum
bioactivity was lower than 13.7 lg/ml against A. hydrophila
within 25 and 30 C. Moreover, S. ruber EKH2 bioactivities
recorded as 18.5 and 27.9 lg/ml against E. tarda and P. aerugi-
nosa respectively, revealed a wide tolerance of temperature
above 30 C. On the other hand, the lower activity against
V. ordalii (38.0 lg/ml) was reported below 30 C. In compar-
ison to our results, initial pH and temperature of the mediumTable 2 Bioactivity showing the appropriate solvent(s) for
extraction of the active agents.
Solvents Inhibition zone diameter (mm)
A.
hydrophila
E.
tarda
P.
aeruginosa
V.
ordalii
Butanol 10 8 9 0
Diethyl ether 17 21 15 0
Ethyl acetate* 35 30 28 12
Benzene 14 15 17 0
Hexane 11 12 0 0
Petroleum
ether
24 25 20 8
* Potent solvent for extraction.
Table 3 Effect of different pHs and temperatures on the
bioactivity of S. ruber EKH2, against the four tested pathogens.
Parameters MIC (lg/ml)
Temp.
(C)
pH Tested pathogens
A.
hydrophila
E.
tarda
P.
aeruginosa
V.
ordalii
28 6 12 24 48 64
28 7* 4 8 12 48
28 8 32 32 48 124
37 6 24 32 64 64
37 7 32 16 24 48
37 8 32 48 64 64
45 6 64 64 64 128
45 7 64 64 64 64
45 8 64 64 128 128
* Optimized conditions for bioactivity.appropriate to induce Streptomyces philanthi RM-1-138 for the
highest antifungal activity were pH 7.5 and 30 C (Boukaew
and Prasertsan, 2014). Rajan and Kannabiran (2014) showed
the highest activity (8 lg/ml) of marine Streptomyces sp.
VITBRK2 at 28 C and pH 7.4. On the other hand,
Streptomyces bangladeshiensis activity was stable within alka-
line pH 8.5 medium at 32.5 C (Al-Bari et al., 2006). The opti-
mum temperature for the Streptomyces strain varied from 30
to 40 C with maximum productivity of 6.2 lg/ml and pH
range from 5 to 9 (Nandhini and Selvam, 2013).
Bioassay of partially puriﬁed extracts
Two grams of ethyl acetate crude extract was obtained from
10 L of fermented broth. One mg of crude was partially puri-
ﬁed through preparative silica gel plate using solvent system
composed of acetone: ethyl acetate (1:2). Three bands were
observed having different Rf values; band (1) 0.96 with brown
color, while, bands (2) and (3) 0.68 and 0.45, respectively, with
UV-Transilluminator. Fractions from TLC plate were col-
lected, weighed and resuspended in ethyl acetate for disc diffu-
sion assay. Signiﬁcant activities were observed against A.
hydrophila as the most sensitive pathogens (Fig. 4); while,
low or no activities for the other three tested organisms.
Similarly, the partially puriﬁed crude extract from marine
Acinetobacter calcoaceticus showed signiﬁcant inhibition zones
against some ﬁsh pathogens such as A. hydrophila, V.
alginolyticus, V. parahaemolyticus and lower activity against
V. harveyi and P. ﬂuorescens (Gopi et al., 2012).
A. hydrophilawas themost sensitive stain showingMIC4 lg/
ml using the ethyl acetate crude extract. This was followed by
16 lg/ml as moderate sensitivity toward E. tarda and P. aerugi-
nosa. The most resistant pathogen was V. ordalii. Fraction 1,
considered the major compound within the extracted crude,
showed the highest activities against the target pathogens (2,
8, 8 and 32 lg/ml, A. hydrophila, E. tarda and P aeruginosa
and V. ordalii, respectively) compared to the other two sepa-
rated fractions (Table 4). Similarly, extractable metabolite from
marine Streptomyces sp. Merv8102 showed antibacterial activi-
ties with MICAVG of 2–8 lg/ml against Gram-positive and
Gram-negative bacteria respectively (El-Gendy et al., 2008).
Arasu et al. (2013), recorded different MIC values from marine
Streptomyces sp. AP-123 against Bacillus subtilis, E. coli, P.
aeruginosa and S. aureus were 25 and 37.5 of 50 and 37.58 lg/
ml, respectively. Another marine Streptomyces sundarbansensis
showed selective activity against methicillin-resistant S. aureus
(MIC = 24 lg/ml) (Djinni et al., 2013). Extractable compounds
from S. bangladeshiensis showed different MICs against
B. subtilis and Salmonella typhi (16 lg/ml), S. aureus and
Shigella dysenteriae (32 lg/ml) (Al-Bari et al., 2006). Marine
extractable product from Streptomyces sp. showed its highest
activities against MRSA 32 lg/ml (Kumar and Rao, 2012).
Bioactive compounds produced by marine Streptomyces strain
showed maximumMIC 16 lg/ml against Klebsiella pneumonia,
E. coli and P. aeruginosa, 32 lg/ml against S. aureus and 64 lg/ml
against B. subtilis (Nandhini and Selvam, 2013).Spectral analysis
Spectral analyses for the potent compound using GC–MS; GC
showed compound with retention time at 21 min 83 s and with
Figure 3 Effect of the interaction between pH and temperature (C) on the bioactivity of S. ruber EKH2 against Aeromonas hydrophila
(A), Edwardsiella tarda (B), Pseudomonas aeruginosa (C) and Vibrio ordalii (D) using response surface plot.
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suggested MS at m= z 149 of compound. It was represented
in this data that this compound corresponds to a molecular
formula of C24H38O4, a dibasic phthalic acid (1,2-benzenedi-
carboxylic acid) (Fig. 5b). IR spectra showed peaks at 2850
(CH2), 1717 (C‚O), 1457 (C‚C), 1030 (C–O) and 818 (C–
H) cm1 (Fig. 6). Natural production of phthalate from S.
bangladeshiensis showed antimicrobial activity against some
pathogenic Gram positive bacteria (Al-Bari et al., 2006).
Dibutyl phthalate, the bioactive compound produced by
Streptomyces albidoﬂavus 321.2, was reported by Roya et al.
(2006). So far, characterization of cytotoxic phthalate from
marine sediment derived actinomycete Streptomyces avidinii
strain SU4 was reported (Sudha and Masilamani, 2012).
Terephthalic acid had been isolated from marine
Streptomyces sp. YIM66017, and determined by spectral
analysis (Zhou et al., 2014). Based on the NIST searchdatabase, the spectral peak of the ethyl acetate extract from
herbs was conﬁrmed as two phthalate derivatives: diethyl
phthalate and dibutyl phthalate (Anusha et al., 2014).
Structure elucidation of many bioactive metabolites from a
marine – Streptomyces sp. was recently reported (Lee et al.,
2014; Rajan and Kannabiran, 2014; Zhang et al., 2015).
Antibiogram of phthalate
It is interesting to note that phthalic acid obtained from S.
ruber EKH2 exhibited a higher anti-virulent activity as shown
before (2, 8, 8 and 32 lg/ml against A. hydrophila, E. tarda, P.
aeruginosa and V. ordalii, respectively) compared to the stan-
dard antibiotics used in ﬁsh therapy. MICAVG of phthalic
acid was 12.5 lg/ml higher than amikacin (AN) and ciproﬂox-
acin (CIP), 22 and 24 lg/ml, respectively; and more superior to
ﬂorfenicol (KF) and rifamycin (RD) with MICAVG 34 and
Figure 4 Agar disc diffusion assay of S. ruber EKH2 crude
extract and fractions of TLC against A. hydrophila (most sensitive
pathogen).
Table 4 Antimicrobial activities of the crude extract and its fractio
Bacterial pathogens MIC (lg/ml)
E.A.* crude extract
Aeromonas hydrophila 4
Edwardsiella tarda 16
Pseudomonas aeruginosa 16
Vibrio ordalii 32
* E.A.: ethyl acetate.
Figure 5 Gas chromatogram (GC) spectral analysis showing the majo
spectral analysis (MS) of phthalic acid in the crude [a] and phthalic a
54 K.M. Barakat, E.A. Beltagy44 lg/ml, respectively, (Fig. 7). Phthalic acid derivative from S.
bangladeshiensis had a good potency against B. subtilis,
S. aureus, S. dysenteriae and S. typhi with MICAVG 24 lg/
ml comparing with amoxycillin trihydrate of MICAVG
23 lg/ml (Al-Bari et al., 2006). A marine Streptomyces
SCSIO 01127 isolated from the South China Sea sediment pro-
duced two new lobophorins showing antibacterial activities
against S. aureus and Enterococcus faecalis with MICAVG
of 8 lg/ml and were better than spiramycin antibiotic that
showed MICAVG of 16 lg/ml (Niu et al., 2011).
Phthalate toxicity
Different concentrations of phthalic acid from 100 to 9000 lg/
ml were tested for its toxicity limit toward A. salina. After 24 h,
the mortality percentage of nauplii was estimated. The obtain-
ing results pointed to the low toxicity with maximum concen-
tration of phthalic acid at 2800 lg/ml and the estimated LC50
was 3.4 ppm (Table 5). Slight toxicity of phthalic acid obtained
from S. ruber EKH2 against brine shrimp compared to phtha-
late ester from Synechococcus lividus extended the survival of
newly hatched brine shrimp (A. salina) larvae at maximum
acute toxicity LC50 = 2715 lg/ml (Acey et al., 2002). From
this result, we may conclude that this compound is a naturalns against ﬁsh pathogens.
Frac.1 Frac.2 Frac.3
2 256 >256
8 256 >256
8 256 >256
32 >256 >256
r peak of the active compound at speciﬁc retention time (A), mass-
cid authentic sample [b] (B).
Figure 6 IR spectrum of phthalic acid derivatives with its related function groups.
Figure 7 Averages of Minimum Inhibitory Concentrations
(MICs) of phthalic acid compared with some antibiotics applied
in ﬁsh therapy.
Table 5 Toxicity of different phthalate concentrations using
Artemia salina.
Phthalate
concentrations
(lg/ml)
Log (Phthalate
concentration)
(ppm)
Mortality percent after 24 h
brine shrimp (Artemia
salina)
100 2.0 0
500 2.7 0
1000 3.0 20
2000 3.3 30
4000 3.6 55
6000 3.8 60
8000 3.8 80
9000 4.0 100
Bioactive phthalate from marine Streptomyces ruber EKH2 55compound with minimum side effects unlike synthetic or
semisynthetic antibiotics.
Conclusion
It can be concluded that phthalate is a new nontoxic bioactive
dibasic acid that could be isolated from marine S. ruber EKH2.
For treating excessive septicemic ﬁsh diseases, as a promising
candidate, the effects of phthalate derivative on mechanical
stress and inﬂammation in association with hemorrhage and
congestion behaviors will be examined in the next stage of
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